Delivery Order 36C26323D0117-36C26323N1013
- Not listed
- This federal contract award, valued at $90,000.00, was issued by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit company specializing in diagnostic testing equipment and reagents. The contract is for the procurement of LIAISON XL testing equipment, which is used for a variety of infectious disease testing including COVID-19 and tuberculosis. Diasorin Inc. has a proven track record as a federal...
- This federal contract award, valued at $188,257, was issued by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit company specializing in diagnostic testing equipment, assays, reagents, and related services. The contract is for DiaSorin LIAISON reagents and preventative maintenance, without any set-aside designation. Diasorin Inc. has a proven track record as a federal contractor, providing...
- This is a $90,000.00 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit company that specializes in diagnostic testing equipment, assays, reagents, and related services. The contract is for the supply of a LIAISON XL diagnostic testing system, which supports COVID-19 and other infectious disease testing. Diasorin Inc. has a proven track record as a federal contractor, providing equipment and services to the VA,...
- This federal contract award to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment, was made by the U.S. Department of Veterans Affairs (VA) through Veterans Integrated Service Network (VISN) 23. The $169,000.00 Firm Fixed Price delivery order contract, which does not have a set-aside designation, is for the provision of COVID-19 tests and analyzers to support the VA's pandemic response and ongoing infectious disease testing...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Diasorin Inc., a subsidiary of the Italian-based medical diagnostics company Diasorin S.P.A. The $12,948.76 firm fixed-price delivery order contract, titled "EXERCISE OY2," does not have a set-aside designation. The contract covers the provision of Diasorin's advanced diagnostic testing equipment, chemiluminescence immunoassay analyzers, reagents, assays, and related technical services to the VA's...
- This is a federal contract award issued by the Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract, identified as DIASORIN XL ANALYZER COST PER TEST IDIQ ORDERING PERIOD 4, is a delivery order with a ceiling value of $87,485.00. It provides the VA's Veterans Integrated Service Network 21 with Diasorin's LIAISON XL chemiluminescence immunoassay analyzers, associated reagents, and related services for diagnostic testing,...
- This is a definitive federal contract awarded by the Veterans Integrated Service Network 23, a civilian agency, to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract, which does not have a set-aside designation, has a ceiling value of $93,000.00 and a period of performance ending on September 30, 2029. Diasorin Inc. is a subsidiary of the Italian-based Diasorin S.P.A. and specializes in providing advanced diagnostic testing equipment, chemiluminescence...
- This is a federal contract award to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, for the supply of DIASORIN REAGENTS AND LIAISON XL ANALYZERS to the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $276,762.20 and is a delivery order under an existing contract vehicle. The award does not involve any set-aside designation. Diasorin Inc. is the prime contractor, and its parent company is Diasorin S.P.A. Both companies have a significant...
- This federal contract award to Diasorin Molecular LLC, a foreign-owned for-profit manufacturer of medical diagnostic products, is for the provision of the LIAISON MDX System and related reagents to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The $101,552 firm-fixed-price purchase order, which was not set aside, supports the VA's COVID-19 pandemic response efforts. Through this and other contracts, Diasorin Molecular LLC has supplied COVID-19 diagnostic tests,...
- This federal contract award to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, is for the provision of reagents, equipment, and related services under a Blanket Purchase Agreement (BPA) call. The $100,000 fixed-price contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense (DoD), to support medical operations across DoD and Department of Veterans Affairs (VA) healthcare facilities. Diasorin has a strong track record as a federal...
- 36C26323D0117Indefinite Delivery Contract
- 36C26323D0117-36C26323N1013Delivery Order
This contract awarded to Diasorin Inc., a foreign-owned, for-profit organization, is a $10,213.90 firm fixed price delivery order placed by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network (VISN) 23. The contract is for the provision of Diasorin's diagnostic testing equipment, assays, reagents, and related services, which are critical to supporting healthcare operations across federal agencies including the VA, Department of Defense (DoD), and Department of Health and Human Services (HHS). Diasorin has a strong track record as a federal contractor, holding several indefinite delivery contracts (IDCs) and a General Services Administration (GSA) Multiple Award Schedule to efficiently supply its specialized diagnostic solutions to the government. These comprehensive contract vehicles allow federal customers to acquire Diasorin's state-of-the-art chemiluminescence immunoassay analyzers, such as the LIAISON XL and LIAISON XS, along with associated reagents, test kits, and technical support for a variety of infectious diseases, including COVID-19, tuberculosis, and varicella. The contract does not have a set-aside designation, reflecting the government's reliance on Diasorin's capabilities to meet critical healthcare needs across agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 8/10/23 |